Supernus Pharmaceuticals reported $28.96M in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbott ABT:US $ 2982M 513M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Aerie Pharmaceuticals AERI:US $ -33.31M 2.2M
Antares Pharma ATRS:US $ 7.22M 1.66M
Aphria Inc APH:CN C$ -353810000 214.73M
Aurora Cannabis Inc ACB:CN -12092000 126.76M
Bristol Myers Squibb BMY:US $ 5289M 67M
Canopy Growth Corp WEED:CN C$ -19538000 412.39M
Cara Therapeutics CARA:US $ -1013000 29.73M
Eisai 4523:JP Y 5564M 50219M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Endo International Ordinary Shares ENDP:US $ 220.65M 39.03M
Marinus Pharmaceuticals MRNS:US $ -19.51M 4.32M
Revance Therapeutics RVNC:US $ -74.38M 2.18M
Supernus Pharmaceuticals SUPN:US $ 28.96M 2.28M
Teva Pharmaceutical Industries TEVA:US $ 807M 13M
United Therapeutics UTHR:US $ 204.4M 12.1M